BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32703494)

  • 1. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
    Yu H; Zhang D; Li Z; Wang M
    Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic role of E2F transcription factors in high-grade glioma.
    Yu H; Li Z; Wang M
    CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
    Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
    Ye L; Guo L; He Z; Wang X; Lin C; Zhang X; Wu S; Bao Y; Yang Q; Song L; Lin H
    Oncotarget; 2016 Apr; 7(17):23757-71. PubMed ID: 26992224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
    Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
    Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer.
    Kim LK; Park SA; Eoh KJ; Heo TH; Kim YT; Kim HJ
    Int J Biol Sci; 2020; 16(2):320-329. PubMed ID: 31929759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.
    Liu K; Wang L; Lou Z; Guo L; Xu Y; Qi H; Fang Z; Mei L; Chen X; Zhang X; Shao J; Xiang X
    Biochem Pharmacol; 2023 Dec; 218():115854. PubMed ID: 37863324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
    Ma Q; Liu Y; Shang L; Yu J; Qu Q
    Oncol Rep; 2017 Dec; 38(6):3367-3375. PubMed ID: 29039578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.